DE69233022D1 - Rekombinante knochenmorphogenetische protein heterodimere, zusammensetzungen und verfahren zur verwendung - Google Patents
Rekombinante knochenmorphogenetische protein heterodimere, zusammensetzungen und verfahren zur verwendungInfo
- Publication number
- DE69233022D1 DE69233022D1 DE69233022T DE69233022T DE69233022D1 DE 69233022 D1 DE69233022 D1 DE 69233022D1 DE 69233022 T DE69233022 T DE 69233022T DE 69233022 T DE69233022 T DE 69233022T DE 69233022 D1 DE69233022 D1 DE 69233022D1
- Authority
- DE
- Germany
- Prior art keywords
- methods
- compositions
- bone morphogenetic
- morphogenetic protein
- recombinant bone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US78749691A | 1991-11-04 | 1991-11-04 | |
US787496 | 1991-11-04 | ||
US86469292A | 1992-04-07 | 1992-04-07 | |
US864692 | 1992-04-07 | ||
PCT/US1992/009430 WO1993009229A1 (en) | 1991-11-04 | 1992-11-02 | Recombinant bone morphogenetic protein heterodimers, compositions and methods of use |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69233022D1 true DE69233022D1 (de) | 2003-05-28 |
DE69233022T2 DE69233022T2 (de) | 2004-02-12 |
Family
ID=27120657
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69233022T Expired - Lifetime DE69233022T2 (de) | 1991-11-04 | 1992-11-02 | Rekombinante knochenmorphogenetische protein heterodimere, zusammensetzungen und verfahren zur verwendung |
Country Status (9)
Country | Link |
---|---|
US (5) | US5866364A (de) |
EP (1) | EP0612348B1 (de) |
JP (2) | JP3504263B2 (de) |
KR (1) | KR100259827B1 (de) |
AT (1) | ATE238417T1 (de) |
AU (1) | AU674500B2 (de) |
DE (1) | DE69233022T2 (de) |
MX (1) | MX9206315A (de) |
WO (1) | WO1993009229A1 (de) |
Families Citing this family (112)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6150328A (en) * | 1986-07-01 | 2000-11-21 | Genetics Institute, Inc. | BMP products |
US5656593A (en) * | 1991-03-11 | 1997-08-12 | Creative Biomolecules, Inc. | Morphogen induced periodontal tissue regeneration |
CA2104678C (en) | 1991-03-11 | 2002-05-14 | Charles M. Cohen | Protein-induced morphogenesis |
ATE238417T1 (de) * | 1991-11-04 | 2003-05-15 | Inst Genetics Llc | Rekombinante knochenmorphogenetische protein heterodimere, zusammensetzungen und verfahren zur verwendung |
US20080070842A1 (en) * | 1991-11-04 | 2008-03-20 | David Israel | Recombinant bone morphogenetic protein heterodimers, compositions and methods of use |
JP4344012B2 (ja) * | 1992-07-31 | 2009-10-14 | ストライカー・コーポレーション | 組織形成因子誘導による神経の再生と修復 |
ATE190352T1 (de) * | 1992-09-03 | 2000-03-15 | Regeneron Pharma | Dorsalgewebe beeinflussender faktor und zusammensetzungen |
WO1994026892A1 (en) * | 1993-05-12 | 1994-11-24 | Genetics Institute, Inc. | Bmp-11 compositions |
EP0626451A3 (de) * | 1993-05-27 | 1997-11-05 | Takeda Chemical Industries, Ltd. | Heterodimere einer TGF-Beta Superfamilie |
AU7605394A (en) * | 1993-09-03 | 1995-03-22 | Regents Of The University Of California, The | Neural tissue affecting factor and compositions |
US6291206B1 (en) * | 1993-09-17 | 2001-09-18 | Genetics Institute, Inc. | BMP receptor proteins |
US5399677A (en) * | 1993-12-07 | 1995-03-21 | Genetics Institute, Inc. | Mutants of bone morphogenetic proteins |
JP3717930B2 (ja) * | 1993-12-07 | 2005-11-16 | ジェネティックス・インスチチュート・リミテッド・ライアビリティ・カンパニー | Bmp−12、bmp−13およびそれらの腱誘導組成物 |
WO1995024210A1 (en) | 1994-03-08 | 1995-09-14 | Genetics Institute, Inc. | Methods and compositions for treatment of periodontal disease and repair of periodontal lesions |
US5906827A (en) † | 1994-06-03 | 1999-05-25 | Creative Biomolecules, Inc. | Matrix for the manufacture of autogenous replacement body parts |
EP0691349A3 (de) * | 1994-07-04 | 1997-09-10 | Hoechst Japan | Dimere Knochenmorphogeneseproteine und ihre Fragmente und Analoge und sie enthaltende pharmazeutische Zubereitungen |
US5679783A (en) * | 1994-11-22 | 1997-10-21 | The Regents Of The University Of California | DNA encoding a tissue differentiation affecting factor |
BR9608019A (pt) | 1995-04-19 | 1999-11-30 | Hoechst Japan | Uma nova proteína e um processo para a preparação da mesma' |
US6638912B2 (en) | 1995-05-01 | 2003-10-28 | The Regents Of The University Of California | Peptide compositions mimicking TGF-β activity |
US5780436A (en) * | 1995-05-01 | 1998-07-14 | The Regents Of The University Of California | Peptide compositions with growth factor-like activity |
US5661127A (en) * | 1995-05-01 | 1997-08-26 | The Regents Of The University Of California | Peptide compositions with growth factor-like activity |
US5635372A (en) * | 1995-05-18 | 1997-06-03 | Genetics Institute, Inc. | BMP-15 compositions |
DK0831884T3 (da) | 1995-06-05 | 2003-11-03 | Inst Genetics Llc | Anvendelse af knoglemorfogenetiske proteiner til heling og reparation af bindevævsbinding |
US5674292A (en) | 1995-06-07 | 1997-10-07 | Stryker Corporation | Terminally sterilized osteogenic devices and preparation thereof |
EP0873424B1 (de) * | 1996-01-10 | 2004-08-25 | The University Of Liverpool | Metastasen induzierende dna's |
US5869041A (en) * | 1996-01-12 | 1999-02-09 | The Miriam Hospital | Delivery of bioactive compounds to an organism |
WO1997031661A1 (en) * | 1996-02-29 | 1997-09-04 | Lindholm T Sam | An osteogenic device and a method for preparing the device |
US6214796B1 (en) | 1996-03-22 | 2001-04-10 | The General Hospital Corporation | Administration of polypeptide growth factors following central nervous system ischemia or trauma |
US5700774A (en) * | 1996-03-26 | 1997-12-23 | Genetics Institute, Inc. | Compositions comprising bone morphogenic proteins and truncated parathyroid hormone related peptide, and methods of inducing cartilage by administration of same |
EP2309261A1 (de) | 1997-05-30 | 2011-04-13 | Stryker Corporation | Verfahren zur Beurteilung von Gewebemorphogenese und- aktivität |
US20030036629A1 (en) * | 1997-12-12 | 2003-02-20 | Barry Foster | Novel tgf-beta protein purification methods |
US6211157B1 (en) | 1998-05-01 | 2001-04-03 | Sulzer Biologics, Inc. | Protein mixtures to induce therapeutic angiogenesis |
US6958149B2 (en) | 1998-10-06 | 2005-10-25 | Stryker Corporation | Repair of larynx, trachea, and other fibrocartilaginous tissues |
US7572440B2 (en) | 1999-07-30 | 2009-08-11 | Stryker Corporation | Method for repairing a defect in an intervertebral disc |
MXPA01003538A (es) | 1998-10-06 | 2005-09-08 | Rush Presbyterian St Luke | Metodo para el tratamiento de quimionucleolisis. |
EP1117805A2 (de) * | 1998-10-07 | 2001-07-25 | STRYKER CORPORATION (a Michigan corporation) | Modifizierte proteine der tgf-beta superfamilie |
US6992066B2 (en) * | 1998-10-16 | 2006-01-31 | Zimmer Orthobiologics, Inc. | Povidone-containing carriers for polypeptide growth factors |
US7087577B2 (en) | 1998-10-16 | 2006-08-08 | Zimmer Orthobiologies, Inc. | Method of promoting natural bypass |
US6727224B1 (en) * | 1999-02-01 | 2004-04-27 | Genetics Institute, Llc. | Methods and compositions for healing and repair of articular cartilage |
DE19906096A1 (de) | 1999-02-13 | 2000-08-17 | Walter Sebald | Protein mit einem Heparin-bindenden Epitop |
US7189392B1 (en) | 1999-10-15 | 2007-03-13 | Genetics Institute, Llc | Injectable carrier formulations of hyaluronic acid derivatives for delivery of osteogenic proteins |
CA2394431C (en) | 1999-12-16 | 2015-06-30 | Jane Relton | Methods of treating central nervous system ischemic or hemorrhagic injury using anti alpha4 integrin antagonists |
US6814756B1 (en) * | 2000-02-04 | 2004-11-09 | Gary K. Michelson | Expandable threaded arcuate interbody spinal fusion implant with lordotic configuration during insertion |
US6500205B1 (en) * | 2000-04-19 | 2002-12-31 | Gary K. Michelson | Expandable threaded arcuate interbody spinal fusion implant with cylindrical configuration during insertion |
EP1645248B8 (de) * | 2000-02-04 | 2010-06-16 | Warsaw Orthopedic, Inc. | Ausdehnbares interspinales Fusionsimplantat mit schwenkbarem Blocker |
US6709458B2 (en) | 2000-02-04 | 2004-03-23 | Gary Karlin Michelson | Expandable push-in arcuate interbody spinal fusion implant with tapered configuration during insertion |
US6716247B2 (en) | 2000-02-04 | 2004-04-06 | Gary K. Michelson | Expandable push-in interbody spinal fusion implant |
US20030104977A1 (en) * | 2000-03-31 | 2003-06-05 | Ugo Ripamonti | Methods for inducing angiogenesis using morphogenic proteins and stimulatory factors |
US6808537B2 (en) * | 2000-07-07 | 2004-10-26 | Gary Karlin Michelson | Expandable implant with interlocking walls |
US6902881B2 (en) | 2000-10-13 | 2005-06-07 | President And Fellows Of Harvard College | Compounds and methods for regulating cell differentiation |
US20030082233A1 (en) * | 2000-12-01 | 2003-05-01 | Lyons Karen M. | Method and composition for modulating bone growth |
JP4133331B2 (ja) * | 2001-02-04 | 2008-08-13 | ウォーソー・オーソペディック・インコーポレーテッド | 拡張可能椎体間脊椎融合インプラントを挿入及び展開するための装置及び方法 |
TW200526779A (en) | 2001-02-08 | 2005-08-16 | Wyeth Corp | Modified and stabilized GDF propeptides and uses thereof |
WO2002099037A2 (en) * | 2001-06-01 | 2002-12-12 | Wyeth | Compositions and methods for systemic administration of sequences encoding bone morphogenetic proteins |
TWI267378B (en) | 2001-06-08 | 2006-12-01 | Wyeth Corp | Calcium phosphate delivery vehicles for osteoinductive proteins |
FI117667B (fi) | 2001-07-05 | 2007-01-15 | Univ Zuerich | Farmaseuttinen koostumus, joka soveltuu käytettäväksi ortopediassa ja hammaslääketieteessä |
US7232802B2 (en) * | 2001-12-21 | 2007-06-19 | Zimmer Orthobiologics, Inc. | Compositions and methods for promoting myocardial and peripheral angiogenesis |
CA2474919A1 (en) * | 2002-02-08 | 2003-08-14 | Wyeth | Formulation comprising bioactive agents and method of using same |
NZ536478A (en) * | 2002-05-17 | 2008-02-29 | Wyeth Corp | Injectable or implantable solid, rod- shaped compositions for intraosseous delivery of osteogenic proteins |
US20040023322A1 (en) * | 2002-08-01 | 2004-02-05 | Goodheart Clyde R. | Method of producing non-recombinant BMP-2 and use thereof |
US7771755B2 (en) * | 2003-09-12 | 2010-08-10 | Wyeth | Injectable calcium phosphate solid rods and pastes for delivery of osteogenic proteins |
EP1778275A2 (de) * | 2004-08-12 | 2007-05-02 | Wyeth | Kombinationstherapie für diabetes, adipositas und herz-kreislauf-erkrankungen unter verwendung von gdf-8-hemmern |
US7473678B2 (en) | 2004-10-14 | 2009-01-06 | Biomimetic Therapeutics, Inc. | Platelet-derived growth factor compositions and methods of use thereof |
WO2006047728A2 (en) * | 2004-10-27 | 2006-05-04 | New York Society For The Ruptured And Crippled Maintaining The Hospital For Special Surgery | Bmp gene and fusion protein |
US7517870B2 (en) | 2004-12-03 | 2009-04-14 | Fondazione Telethon | Use of compounds that interfere with the hedgehog signaling pathway for the manufacture of a medicament for preventing, inhibiting, and/or reversing ocular diseases related with ocular neovascularization |
WO2006081379A1 (en) * | 2005-01-26 | 2006-08-03 | Wyeth | Use of sfrps as markers of bmp activity |
KR100775958B1 (ko) * | 2005-03-30 | 2007-11-13 | 김정문 | 조직재생 기능을 가지는 비활성 폴리펩티드 및 그 제조방법 |
WO2006104306A1 (en) * | 2005-03-30 | 2006-10-05 | Jung Moon Kim | Non-activated polypeptides having a function of tissue regeneration and method for preparing the same |
WO2006105359A2 (en) * | 2005-03-30 | 2006-10-05 | Wyeth | Methods for stimulating hair growth by administering bmps |
US20070056050A1 (en) * | 2005-06-29 | 2007-03-08 | Clokie Cameron M L | PRODUCTION OF BONE MORPHOGENIC PROTEINS (BMPs) IN TRANSGENIC MAMMALS |
US7771995B2 (en) * | 2005-11-14 | 2010-08-10 | Merial Limited | Plasmid encoding human BMP-7 |
US8147860B2 (en) | 2005-12-06 | 2012-04-03 | Etex Corporation | Porous calcium phosphate bone material |
EP2311505B1 (de) | 2006-02-09 | 2013-11-06 | BioMimetic Therapeutics, LLC | Zusammensetzungen und Verfahren zur Behandlung von Knochen |
US7838022B2 (en) | 2006-05-01 | 2010-11-23 | Warsaw Orthopedic, Inc | Malleable implants containing demineralized bone matrix |
US9161967B2 (en) | 2006-06-30 | 2015-10-20 | Biomimetic Therapeutics, Llc | Compositions and methods for treating the vertebral column |
AU2007269712B2 (en) | 2006-06-30 | 2013-02-07 | Biomimetic Therapeutics, Llc | PDGF-biomatrix compositions and methods for treating rotator cuff injuries |
US8524265B2 (en) | 2006-08-17 | 2013-09-03 | Warsaw Orthopedic, Inc. | Medical implant sheets useful for tissue regeneration |
AU2007234612B2 (en) | 2006-12-14 | 2013-06-27 | Johnson & Johnson Regenerative Therapeutics, Llc | Protein stabilization formulations |
JP5452230B2 (ja) | 2006-12-21 | 2014-03-26 | ストライカー コーポレイション | 生物学的因子の結晶、高分子ゲルおよび粒子懸濁液を含む持続放出処方物 |
PT3345607T (pt) | 2006-12-29 | 2022-11-21 | Ossifi Mab Llc | Métodos para alterar o crescimento ósseo por administração de antagonista ou agonista de sost ou wise |
WO2008144900A1 (en) * | 2007-05-25 | 2008-12-04 | Peel Sean A | A method of enhancing recombinant protein production |
US7678764B2 (en) | 2007-06-29 | 2010-03-16 | Johnson & Johnson Regenerative Therapeutics, Llc | Protein formulations for use at elevated temperatures |
EP2019117A1 (de) * | 2007-07-27 | 2009-01-28 | BIOPHARM GESELLSCHAFT ZUR BIOTECHNOLOGISCHEN ENTWICKLUNG VON PHARMAKA mbH | Optimiertes Reinigungsverfahren für rekombinantes Wachstumsfaktorprotein |
CN101801405A (zh) | 2007-08-07 | 2010-08-11 | 先进科技及再生医学有限责任公司 | 包含于酸性水溶液中的gdf-5的蛋白质配方 |
US20090061002A1 (en) | 2007-09-05 | 2009-03-05 | Venbrocks Rudolf A | Calcium phospate based delivery of growth and differentiation factors to compromised bone |
US9700584B2 (en) | 2007-12-21 | 2017-07-11 | Rti Surgical, Inc. | Osteoinductive putties and methods of making and using such putties |
JP2011514331A (ja) | 2008-02-13 | 2011-05-06 | キース フルスカ, | 血管硬化症の治療における使用のためのbmp−7 |
JP5599778B2 (ja) | 2008-04-14 | 2014-10-01 | デピュイ・シンセス・プロダクツ・エルエルシー | 液体緩衝gdf−5製剤 |
CA2653866A1 (en) * | 2008-07-03 | 2010-01-03 | Induce Biologics Inc. | Use of immobilized antagonists for enhancing growth factor containing bioimplant effectiveness |
JP5816553B2 (ja) | 2008-09-09 | 2015-11-18 | バイオミメティック セラピューティクス, エルエルシー | 腱または靭帯の傷害を処置するための血小板由来成長因子組成物および方法 |
CA2752157A1 (en) | 2009-02-12 | 2010-08-19 | Stryker Corporation | Peripheral administration of proteins including tgf-.beta. superfamily members for systemic treatment of disorders and disease |
CA2752160A1 (en) | 2009-02-12 | 2010-08-19 | Stryker Corporation | Compositions and methods for minimally-invasive systemic delivery of proteins including tgf-.beta. superfamily members |
US20120148539A1 (en) | 2009-03-24 | 2012-06-14 | Moulay Hicham Alaoui-Ismaili | Methods and Compositions for Tissue Engineering |
US8609127B2 (en) | 2009-04-03 | 2013-12-17 | Warsaw Orthopedic, Inc. | Medical implant with bioactive material and method of making the medical implant |
WO2011031856A1 (en) | 2009-09-09 | 2011-03-17 | Stryker Corporation | Bmp -7 for use in treating pain induced by injuries and diseases of an articular joint |
CA2774024A1 (en) | 2009-09-17 | 2011-03-24 | Stryker Corporation | Buffers for controlling the ph of bone morphogenetic proteins |
CN102822197A (zh) | 2009-12-22 | 2012-12-12 | 史赛克公司 | 具有降低的免疫原性的bmp-7变体 |
MX2012009687A (es) | 2010-02-22 | 2012-11-29 | Biomimetic Therapeutics Inc | Metodos y composiciones de factor de crecimiento derivado de plaquetas y métodos para el tratamiento de tendinopatías. |
US9856305B2 (en) * | 2010-08-20 | 2018-01-02 | Wyeth Llc | Designer osteogenic proteins |
AU2012243410B8 (en) | 2011-04-11 | 2016-11-17 | Red Rock Regeneration Inc. | System and method for multiphasic release of growth factors |
IN2014DN08829A (de) | 2012-04-11 | 2015-05-22 | Induce Biolog Inc | |
US10034945B2 (en) | 2012-07-13 | 2018-07-31 | Trustees Of Tufts College | Silk powder compaction for production of constructs with high mechanical strength and stiffness |
CA2905455A1 (en) * | 2013-03-14 | 2014-10-02 | Genzyme Corporation | Thermo-sensitive bone growth compositions |
CN105120863B (zh) | 2013-03-14 | 2021-06-04 | 奥斯特克有限公司 | 促进骨生长的烷基胺骆驼蓬碱衍生物 |
CN104163865A (zh) * | 2014-07-01 | 2014-11-26 | 杭州瑞固生物技术有限公司 | 优化的重组人骨形态发生蛋白质-2的dna序列及其编码蛋白质 |
KR101744763B1 (ko) * | 2014-12-19 | 2017-06-09 | (주)케어젠 | Bmp 유래 펩타이드 및 이의 용도 |
WO2016109555A1 (en) | 2014-12-29 | 2016-07-07 | Bioventus, Llc | Systems and methods for improved delivery of osteoinductive molecules in bone repair |
CN108430458B (zh) | 2015-10-26 | 2022-05-10 | 哈佛学院院长等 | 还原和氧化的多糖及其使用方法 |
NZ754942A (en) | 2016-12-30 | 2023-02-24 | Biogend Therapeutics Co Ltd | Recombinant polypeptides, compositions, and methods thereof |
US11596712B2 (en) | 2017-10-19 | 2023-03-07 | Genera Istrazivanja D.O.O. | Autologous bone graft substitute composition |
AU2019320773A1 (en) | 2018-08-14 | 2021-03-04 | Osteoqc Inc. | Fluoro β-carboline compounds |
BR112021002614A2 (pt) | 2018-08-14 | 2021-05-04 | Osteoqc Inc. | compostos pirrol-dipiridina |
Family Cites Families (175)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2465357A (en) | 1944-08-14 | 1949-03-29 | Upjohn Co | Therapeutic sponge and method of making |
CH563767A5 (de) | 1973-01-30 | 1975-07-15 | Pheulpin Jean | |
US4468464A (en) | 1974-11-04 | 1984-08-28 | The Board Of Trustees Of The Leland Stanford Junior University | Biologically functional molecular chimeras |
DE2657370C2 (de) | 1976-12-17 | 1982-11-11 | Hans Dr.med. Dr.med.dent. 8000 München Scheicher | Mittel zum Bedecken und/oder Ausfüllen von Knochendefekten |
DE2732848A1 (de) | 1977-07-18 | 1979-02-08 | Schering Ag | Diurethane, herbizide mittel enthaltend diese verbindungen sowie verfahren zu ihrer herstellung |
US4399216A (en) | 1980-02-25 | 1983-08-16 | The Trustees Of Columbia University | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
US4619989A (en) | 1981-05-05 | 1986-10-28 | The Regents Of The University Of Cal. | Bone morphogenetic protein composition |
US4455256A (en) * | 1981-05-05 | 1984-06-19 | The Regents Of The University Of California | Bone morphogenetic protein |
US4761471A (en) * | 1980-08-04 | 1988-08-02 | The Regents Of The University Of California | Bone morphogenetic protein composition |
US4294753A (en) * | 1980-08-04 | 1981-10-13 | The Regents Of The University Of California | Bone morphogenetic protein process |
US4789732A (en) * | 1980-08-04 | 1988-12-06 | Regents Of The University Of California | Bone morphogenetic protein composition |
PH19942A (en) | 1980-11-18 | 1986-08-14 | Sintex Inc | Microencapsulation of water soluble polypeptides |
US4419446A (en) | 1980-12-31 | 1983-12-06 | The United States Of America As Represented By The Department Of Health And Human Services | Recombinant DNA process utilizing a papilloma virus DNA as a vector |
IE52535B1 (en) | 1981-02-16 | 1987-12-09 | Ici Plc | Continuous release pharmaceutical compositions |
US4727028A (en) | 1981-06-22 | 1988-02-23 | Eli Lilly And Company | Recombinant DNA cloning vectors and the eukaryotic and prokaryotic transformants thereof |
US4472840A (en) | 1981-09-21 | 1984-09-25 | Jefferies Steven R | Method of inducing osseous formation by implanting bone graft material |
US4394370A (en) | 1981-09-21 | 1983-07-19 | Jefferies Steven R | Bone graft material for osseous defects and method of making same |
US4474181A (en) | 1982-02-18 | 1984-10-02 | Schenck Robert R | Method and apparatus for anastomosing small blood vessels |
IL68218A (en) | 1983-03-23 | 1985-12-31 | Univ Ramot | Compositions for cartilage repair comprising embryonal chondrocytes |
US4434094A (en) | 1983-04-12 | 1984-02-28 | Collagen Corporation | Partially purified osteogenic factor and process for preparing same from demineralized bone |
CA1229789A (en) | 1983-06-06 | 1987-12-01 | David Baylink | Polypeptides exhibiting skeletal growth factor activity |
US4795804A (en) | 1983-08-16 | 1989-01-03 | The Regents Of The University Of California | Bone morphogenetic agents |
US4923805A (en) * | 1983-11-02 | 1990-05-08 | Integrated Genetics, Inc. | Fsh |
US4703008A (en) | 1983-12-13 | 1987-10-27 | Kiren-Amgen, Inc. | DNA sequences encoding erythropoietin |
GB8334498D0 (en) * | 1983-12-24 | 1984-02-01 | Beecham Group Plc | Compounds |
NZ210699A (en) | 1984-01-04 | 1989-06-28 | Int Genetic Eng | Isolation of an osteogenic protein of the p3 immunologically related family |
US4804744A (en) * | 1984-01-04 | 1989-02-14 | International Genetic Engineering, Inc. | Osteogenic factors |
DK518384A (da) | 1984-01-31 | 1985-07-01 | Idaho Res Found | Vektor til fremstilling af et gen-produkt i insektceller, fremgangsmaade til dens fremstilling samt dens anvendelse |
US4608199A (en) * | 1984-03-20 | 1986-08-26 | Arnold Caplan | Bone protein purification process |
US4662884A (en) | 1984-04-25 | 1987-05-05 | University Of Utah Research Foundation | Prostheses and methods for promoting nerve regeneration |
US4596574A (en) | 1984-05-14 | 1986-06-24 | The Regents Of The University Of California | Biodegradable porous ceramic delivery system for bone morphogenetic protein |
CA1341617C (en) | 1984-06-08 | 2011-06-28 | Henry George Burger | Inhibin isolated from ovarian follicular fluid |
US4868161A (en) | 1984-06-29 | 1989-09-19 | City Of Hope | Method for promoting nerve regeneration |
US4627982A (en) * | 1984-07-16 | 1986-12-09 | Collagen Corporation | Partially purified bone-inducing factor |
DE3588058T3 (de) * | 1984-07-16 | 2005-04-07 | Celtrix Pharmaceuticals, Inc., Palo Alto | Knorpel-induzierende Polypeptid-Faktoren aus Knochen |
US4843063A (en) * | 1984-07-16 | 1989-06-27 | Collagen Corporation | Polypeptide cartilage-inducing factors found in bone |
EP0177343B1 (de) | 1984-10-05 | 1992-07-22 | Genentech, Inc. | DNA, Zellkulturen und Verfahren zur Sekretion von heterologen Proteinen und periplasmische Proteinrückgewinnung |
US5187263A (en) * | 1984-10-12 | 1993-02-16 | Zymogenetics, Inc. | Expression of biologically active PDGE analogs in eucaryotic cells |
US4769328A (en) * | 1984-10-12 | 1988-09-06 | Zymogenetics Inc. | Expression of biologically active PDGF analogs in yeast |
US4563350A (en) * | 1984-10-24 | 1986-01-07 | Collagen Corporation | Inductive collagen based bone repair preparations |
KR930007429B1 (ko) | 1984-12-27 | 1993-08-10 | 산도리 가부시기가이샤 | 인터페론의 정제방법 |
US4886747A (en) * | 1985-03-22 | 1989-12-12 | Genentech, Inc. | Nucleic acid encoding TGF-β and its uses |
US4766067A (en) | 1985-05-31 | 1988-08-23 | President And Fellows Of Harvard College | Gene amplification |
US4681763A (en) * | 1985-06-11 | 1987-07-21 | University Of Medicine And Dentistry Of New Jersey | Composition for stimulating bone growth |
US4851521A (en) | 1985-07-08 | 1989-07-25 | Fidia, S.P.A. | Esters of hyaluronic acid |
US5215893A (en) | 1985-10-03 | 1993-06-01 | Genentech, Inc. | Nucleic acid encoding the ba chain prodomains of inhibin and method for synthesizing polypeptides using such nucleic acid |
US4798885A (en) * | 1986-02-07 | 1989-01-17 | Genentech, Inc. | Compositions of hormonally active human and porcine inhibin containing an α chain and 62 chain |
NZ231899A (en) | 1985-10-03 | 1991-07-26 | Genentech Inc | Human or porcine inhibin peptide compositions and dna encoding them |
US5089396A (en) | 1985-10-03 | 1992-02-18 | Genentech, Inc. | Nucleic acid encoding β chain prodomains of inhibin and method for synthesizing polypeptides using such nucleic acid |
US4737578A (en) * | 1986-02-10 | 1988-04-12 | The Salk Institute For Biological Studies | Human inhibin |
EP0241809B1 (de) | 1986-04-16 | 1990-08-08 | ASTA Pharma Aktiengesellschaft | Synergistische Kombination von Amantadin und Selegilin |
US4758233A (en) | 1986-04-22 | 1988-07-19 | N.J. Phillips TPY. Limited | Cream applicator |
NL8601328A (nl) | 1986-05-23 | 1987-12-16 | Langen Research | Inrichting voor het met een massa, in het bijzonder pasteuze massa, injekteren van vlees. |
US5013649A (en) | 1986-07-01 | 1991-05-07 | Genetics Institute, Inc. | DNA sequences encoding osteoinductive products |
US4877864A (en) | 1987-03-26 | 1989-10-31 | Genetics Institute, Inc. | Osteoinductive factors |
US5108922A (en) | 1986-07-01 | 1992-04-28 | Genetics Institute, Inc. | DNA sequences encoding BMP-1 products |
US5366875A (en) | 1986-07-01 | 1994-11-22 | Genetics Institute, Inc. | Methods for producing BMP-7 proteins |
US5459047A (en) | 1986-07-01 | 1995-10-17 | Genetics Institute, Inc. | BMP-6 proteins |
US6150328A (en) | 1986-07-01 | 2000-11-21 | Genetics Institute, Inc. | BMP products |
US5939388A (en) | 1986-07-01 | 1999-08-17 | Rosen; Vicki A. | Methods of administering BMP-5 compositions |
US5631142A (en) | 1986-07-01 | 1997-05-20 | Genetics Institute, Inc. | Compositions comprising bone morphogenetic protein-2 (BMP-2) |
US6432919B1 (en) | 1986-07-01 | 2002-08-13 | Genetics Institute, Inc. | Bone morphogenetic protein-3 and compositions |
US5187076A (en) * | 1986-07-01 | 1993-02-16 | Genetics Institute, Inc. | DNA sequences encoding BMP-6 proteins |
ZA874681B (en) * | 1986-07-01 | 1988-04-27 | Genetics Inst | Novel osteoinductive factors |
US5543394A (en) | 1986-07-01 | 1996-08-06 | Genetics Institute, Inc. | Bone morphogenetic protein 5(BMP-5) compositions |
IL83003A (en) | 1986-07-01 | 1995-07-31 | Genetics Inst | Factors that soak bone formation |
US5106748A (en) * | 1986-07-01 | 1992-04-21 | Genetics Institute, Inc. | Dna sequences encoding 5 proteins |
US5019087A (en) | 1986-10-06 | 1991-05-28 | American Biomaterials Corporation | Nerve regeneration conduit |
US5124316A (en) | 1986-11-14 | 1992-06-23 | President And Fellows Of Harvard College | Method for periodontal regeneration |
US5457092A (en) | 1987-07-30 | 1995-10-10 | Gesellschaft Fur Biotechnologische Forschung Mbh (Gbf) | Methods of promoting bone growth in mammals comprising administration of modified parathyroid hormone |
US5041538A (en) | 1987-08-28 | 1991-08-20 | The Salk Institute For Biological Studies | Mammalian follistatin |
US5202120A (en) | 1987-09-11 | 1993-04-13 | Case Western Reserve University | Methods of reducing glial scar formation and promoting axon and blood vessel growth and/or regeneration through the use of activated immature astrocytes |
US5147399A (en) | 1988-02-01 | 1992-09-15 | Dellon Arnold L | Method of treating nerve defects through use of a bioabsorbable surgical device |
IT1215881B (it) | 1988-02-16 | 1990-02-22 | Giancarlo Foresti | Sussidio chirurgico ad azione osteotropa. |
AU3433989A (en) * | 1988-04-06 | 1989-11-03 | Celtrix Laboratories, Inc. | Bone-inducing protein |
US5266683A (en) * | 1988-04-08 | 1993-11-30 | Stryker Corporation | Osteogenic proteins |
US5108753A (en) * | 1988-04-08 | 1992-04-28 | Creative Biomolecules | Osteogenic devices |
US6586388B2 (en) | 1988-04-08 | 2003-07-01 | Stryker Corporation | Method of using recombinant osteogenic protein to repair bone or cartilage defects |
JPH03503649A (ja) * | 1988-04-08 | 1991-08-15 | ジェネティックス・インスティテュート・インコーポレイテッド | 硬骨および軟骨誘導組成物 |
US5354557A (en) | 1988-04-08 | 1994-10-11 | Stryker Corporation | Osteogenic devices |
US5258494A (en) * | 1988-04-08 | 1993-11-02 | Stryker Corporation | Osteogenic proteins |
US4968590A (en) * | 1988-04-08 | 1990-11-06 | Stryker Corporation | Osteogenic proteins and polypeptides |
AU628050B2 (en) * | 1988-04-08 | 1992-09-10 | Stryker Corporation | Biosynthetic osteogenic proteins and osteogenic devices containing them |
US5011691A (en) * | 1988-08-15 | 1991-04-30 | Stryker Corporation | Osteogenic devices |
US5024841A (en) | 1988-06-30 | 1991-06-18 | Collagen Corporation | Collagen wound healing matrices and process for their production |
US5071834A (en) | 1988-09-16 | 1991-12-10 | Genentech, Inc. | Purified activin B composition |
US5106626A (en) * | 1988-10-11 | 1992-04-21 | International Genetic Engineering, Inc. | Osteogenic factors |
US5284756A (en) * | 1988-10-11 | 1994-02-08 | Lynn Grinna | Heterodimeric osteogenic factor |
US4955892A (en) | 1988-10-24 | 1990-09-11 | Louisiana State University | Neural cell adhesion protein nerve prosthesis |
US5457038A (en) | 1988-11-10 | 1995-10-10 | Genetics Institute, Inc. | Natural killer stimulatory factor |
US5011486A (en) | 1988-11-18 | 1991-04-30 | Brown University Research Foundation | Composite nerve guidance channels |
US5162430A (en) | 1988-11-21 | 1992-11-10 | Collagen Corporation | Collagen-polymer conjugates |
US4920962A (en) | 1988-11-23 | 1990-05-01 | Claude Proulx | Splint-like element for use in end-to-end nerve suture |
US5217867A (en) | 1988-11-30 | 1993-06-08 | The Salk Institute For Biological Studies | Receptors: their identification, characterization, preparation and use |
EP0411096A1 (de) | 1989-02-23 | 1991-02-06 | Gesellschaft für Biotechnologische Forschung mbH (GBF) | Pth-varianten kodierende dna-sequenzen, pth-varianten, expressionsvektor, bakterieller wirt, verwendung und therapeutische zusammensetzung |
ATE162223T1 (de) * | 1989-03-28 | 1998-01-15 | Genetics Inst | Osteoinduktive zusammensetzungen |
US4963146A (en) | 1989-04-20 | 1990-10-16 | Colla-Tec Incorporated | Multi-layered, semi-permeable conduit for nerve regeneration |
US5026381A (en) | 1989-04-20 | 1991-06-25 | Colla-Tec, Incorporated | Multi-layered, semi-permeable conduit for nerve regeneration comprised of type 1 collagen, its method of manufacture and a method of nerve regeneration using said conduit |
US5166322A (en) | 1989-04-21 | 1992-11-24 | Genetics Institute | Cysteine added variants of interleukin-3 and chemical modifications thereof |
PT94241A (pt) | 1989-06-02 | 1991-02-08 | Chiron Corp | Processo para a preparacao de factor calcificacao ossea e de composicoes farmaceuticas que os contem |
CA2017466A1 (en) * | 1989-06-02 | 1990-12-02 | Michael C. Kiefer | Bone calcification factor |
US5399346A (en) * | 1989-06-14 | 1995-03-21 | The United States Of America As Represented By The Department Of Health And Human Services | Gene therapy |
WO1991000103A1 (en) | 1989-06-29 | 1991-01-10 | The United States Of America, Represented By The Secretary, United States Department Of Commerce | Method for protecting bone marrow against chemotherapeutic drugs and radiation therapy using transforming growth factor beta 1 |
CA2020729A1 (en) * | 1989-07-19 | 1991-01-20 | Michael C. Kiefer | Bone morphogenetic protein |
US5324519A (en) | 1989-07-24 | 1994-06-28 | Atrix Laboratories, Inc. | Biodegradable polymer composition |
US5194596A (en) * | 1989-07-27 | 1993-03-16 | California Biotechnology Inc. | Production of vascular endothelial cell growth factor |
WO1991002744A1 (en) * | 1989-08-21 | 1991-03-07 | Celtrix Laboratories, Inc. | Bone-specific protein |
US5422340A (en) | 1989-09-01 | 1995-06-06 | Ammann; Arthur J. | TGF-βformulation for inducing bone growth |
DE69027961T2 (de) * | 1989-09-06 | 1997-01-09 | Takeda Chemical Industries Ltd | Protein, DNA und ihre Verwendung |
DE69032424T2 (de) * | 1989-10-17 | 1999-02-04 | Stryker Corp | Osteogene vorrichtungen |
US5236456A (en) | 1989-11-09 | 1993-08-17 | Osteotech, Inc. | Osteogenic composition and implant containing same |
US5215895A (en) | 1989-11-22 | 1993-06-01 | Genetics Institute, Inc. | Dna encoding a mammalian cytokine, interleukin-11 |
GB8927546D0 (en) * | 1989-12-06 | 1990-02-07 | Ciba Geigy | Process for the production of biologically active tgf-beta |
US5166190A (en) | 1990-01-08 | 1992-11-24 | Genentech, Inc. | Method for increasing fertility in males |
US5256418A (en) | 1990-04-06 | 1993-10-26 | Organogenesis, Inc. | Collagen constructs |
US5290271A (en) | 1990-05-14 | 1994-03-01 | Jernberg Gary R | Surgical implant and method for controlled release of chemotherapeutic agents |
ATE209251T1 (de) | 1990-05-16 | 2001-12-15 | Genetics Inst | Knochen- und knorpel-bildung hervorrufende proteine |
US5688678A (en) | 1990-05-16 | 1997-11-18 | Genetics Institute, Inc. | DNA encoding and methods for producing BMP-8 proteins |
US5168050A (en) * | 1990-05-24 | 1992-12-01 | Genentech, Inc. | Mammalian expression of the bone morphogenetic protein-2b using bmp2a/bmp2b fusion |
US5218090A (en) | 1990-06-12 | 1993-06-08 | Warner-Lambert Company | EGF receptor truncates |
US5364839A (en) | 1990-06-18 | 1994-11-15 | Genetics Institute, Inc. | Osteoinductive pharmaceutical formulations |
US5206028A (en) | 1991-02-11 | 1993-04-27 | Li Shu Tung | Dense collagen membrane matrices for medical uses |
US5208219A (en) | 1991-02-14 | 1993-05-04 | Celtrix Pharmaceuticals Inc. | Method for inducing bone growth |
US6395883B1 (en) * | 1991-03-11 | 2002-05-28 | Curis, Inc. | Soluble morphogenic protein complex compositions of matter |
US5318898A (en) | 1991-04-02 | 1994-06-07 | Genetics Institute, Inc. | Production of recombinant bone-inducing proteins |
US5118667A (en) | 1991-05-03 | 1992-06-02 | Celtrix Pharmaceuticals, Inc. | Bone growth factors and inhibitors of bone resorption for promoting bone formation |
JPH07500315A (ja) | 1991-05-10 | 1995-01-12 | セルトリックス ファーマシューティカルズ,インコーポレイテッド | 骨成長因子の標的送達 |
US5229495A (en) | 1991-06-18 | 1993-07-20 | Ludwig Institute For Cancer Research | Substantially pure receptor like TGF-β 1 binding molecules and uses thereof |
US5216126A (en) | 1991-06-19 | 1993-06-01 | Genentech, Inc. | Receptor polypeptides and their production and uses |
US6287816B1 (en) | 1991-06-25 | 2001-09-11 | Genetics Institute, Inc. | BMP-9 compositions |
KR100255415B1 (ko) | 1991-06-25 | 2000-05-01 | 브루스 엠. 에이센 | 비엠피-9 조성물 |
US5356629A (en) | 1991-07-12 | 1994-10-18 | United States Surgical Corporation | Composition for effecting bone repair |
US5306307A (en) | 1991-07-22 | 1994-04-26 | Calcitek, Inc. | Spinal disk implant |
US5270300A (en) | 1991-09-06 | 1993-12-14 | Robert Francis Shaw | Methods and compositions for the treatment and repair of defects or lesions in cartilage or bone |
US5171579A (en) | 1991-10-11 | 1992-12-15 | Genetics Institute, Inc. | Formulations of blood clot-polymer matrix for delivery of osteogenic proteins |
ATE238417T1 (de) | 1991-11-04 | 2003-05-15 | Inst Genetics Llc | Rekombinante knochenmorphogenetische protein heterodimere, zusammensetzungen und verfahren zur verwendung |
SE469653B (sv) | 1992-01-13 | 1993-08-16 | Lucocer Ab | Poroest implantat |
DE69331096T2 (de) | 1992-02-28 | 2002-08-14 | Cohesion Tech Inc | Injektierbare, keramische verbindungen sowie verfahren zur deren herstellung und anwendung |
AU3920693A (en) | 1992-03-18 | 1993-10-21 | General Hospital Corporation, The | Four novel receptors of the TGF-beta receptor family |
IT1259100B (it) | 1992-05-20 | 1996-03-11 | Lanfranco Callegaro | Uso di idrogeli per il bloccaggio di sistemi protesici |
US5420243A (en) | 1993-01-26 | 1995-05-30 | Celtrix Pharmaceuticals, Inc. | Biologically active TGF-β2 peptides |
EP1333035A3 (de) | 1993-03-19 | 2004-07-07 | The Johns Hopkins University School Of Medicine | Wachstumsdifferenzierungsfaktor-8 |
GB9308060D0 (en) | 1993-04-19 | 1993-06-02 | Cancer Res Campaign Tech | Stem cell inhibitor |
WO1994026892A1 (en) | 1993-05-12 | 1994-11-24 | Genetics Institute, Inc. | Bmp-11 compositions |
US5637480A (en) | 1993-05-12 | 1997-06-10 | Genetics Institute, Inc. | DNA molecules encoding bone morphogenetic protein-10 |
EP0626451A3 (de) * | 1993-05-27 | 1997-11-05 | Takeda Chemical Industries, Ltd. | Heterodimere einer TGF-Beta Superfamilie |
US5447725A (en) | 1993-06-11 | 1995-09-05 | The Procter & Gamble Company | Methods for aiding periodontal tissue regeneration |
EP0717633A4 (de) | 1993-07-09 | 1998-05-20 | Univ Johns Hopkins Med | Wachstums-differenzierungsfaktor-7 |
DK0716610T3 (da) | 1993-08-26 | 2006-09-04 | Genetics Inst Llc | Humane knogle-morfogenetiske proteiner til anvendelse ved neural regenerering |
US5455041A (en) | 1993-09-13 | 1995-10-03 | Research Foundation Of State University Of New York At Buffalo | Method for inducing periodontal tissue regeneration |
US6291206B1 (en) | 1993-09-17 | 2001-09-18 | Genetics Institute, Inc. | BMP receptor proteins |
CA2175049A1 (en) | 1993-10-28 | 1995-05-04 | Timothy Ringeisen | Improved process and device for treating and healing a bone void |
JP3717930B2 (ja) | 1993-12-07 | 2005-11-16 | ジェネティックス・インスチチュート・リミテッド・ライアビリティ・カンパニー | Bmp−12、bmp−13およびそれらの腱誘導組成物 |
US6027919A (en) | 1993-12-07 | 2000-02-22 | Genetics Institute, Inc. | BMP-12 and BMP-13 proteins and DNA encoding them |
US5399677A (en) | 1993-12-07 | 1995-03-21 | Genetics Institute, Inc. | Mutants of bone morphogenetic proteins |
US5556767A (en) | 1993-12-22 | 1996-09-17 | Human Genome Sciences, Inc. | Polynucleotide encoding macrophage inflammatory protein γ |
US5723331A (en) | 1994-05-05 | 1998-03-03 | Genzyme Corporation | Methods and compositions for the repair of articular cartilage defects in mammals |
US5520923A (en) | 1994-09-19 | 1996-05-28 | Genetics Institute, Inc. | Formulations for delivery of osteogenic proteins |
US5545616A (en) | 1994-09-22 | 1996-08-13 | Genentech, Inc. | Method for predicting and/or preventing preterm labor |
US5693779A (en) | 1994-11-08 | 1997-12-02 | The United States Of America As Represented By The Department Of Health And Human Services | Production and use of anti-dorsalizing morphogenetic protein |
EP0741187A2 (de) | 1995-05-05 | 1996-11-06 | F. Hoffmann-La Roche Ag | Rekombinante Obesitäts-(OB)-Proteine |
US5635372A (en) | 1995-05-18 | 1997-06-03 | Genetics Institute, Inc. | BMP-15 compositions |
DK0831884T3 (da) | 1995-06-05 | 2003-11-03 | Inst Genetics Llc | Anvendelse af knoglemorfogenetiske proteiner til heling og reparation af bindevævsbinding |
US5674292A (en) | 1995-06-07 | 1997-10-07 | Stryker Corporation | Terminally sterilized osteogenic devices and preparation thereof |
US5752974A (en) | 1995-12-18 | 1998-05-19 | Collagen Corporation | Injectable or implantable biomaterials for filling or blocking lumens and voids of the body |
ATE237285T1 (de) | 1995-12-18 | 2003-05-15 | Jens Schug | Medizinisches implantat |
US5700774A (en) | 1996-03-26 | 1997-12-23 | Genetics Institute, Inc. | Compositions comprising bone morphogenic proteins and truncated parathyroid hormone related peptide, and methods of inducing cartilage by administration of same |
CA2256400A1 (en) | 1996-05-28 | 1997-12-04 | Brown University Research Foundation | Hyaluronan based biodegradable scaffolds for tissue repair |
US5813411A (en) | 1996-08-20 | 1998-09-29 | Menlo Care, Inc. | Method of deforming tissue with a swollen hydrogel |
US5965403A (en) | 1996-09-18 | 1999-10-12 | Genetics Institute, Inc. | Nucleic acids encoding bone morphogenic protein-16 (BMP-16) |
US6034062A (en) | 1997-03-13 | 2000-03-07 | Genetics Institute, Inc. | Bone morphogenetic protein (BMP)-9 compositions and their uses |
US6001352A (en) | 1997-03-31 | 1999-12-14 | Osteobiologics, Inc. | Resurfacing cartilage defects with chondrocytes proliferated without differentiation using platelet-derived growth factor |
US5972368A (en) | 1997-06-11 | 1999-10-26 | Sdgi Holdings, Inc. | Bone graft composites and spacers |
US6004937A (en) | 1998-03-09 | 1999-12-21 | Genetics Institute, Inc. | Use of follistatin to modulate growth and differentiation factor 8 [GDF-8] and bone morphogenic protein 11 [BMP-11] |
IT1302534B1 (it) | 1998-12-21 | 2000-09-05 | Fidia Advanced Biopolymers Srl | Composizioni iniettabili, biocompatibili e biodegradabili comprendentialmeno un derivato dell'acido ialuronico, cellule condrogeniche, per |
-
1992
- 1992-11-02 AT AT92924237T patent/ATE238417T1/de not_active IP Right Cessation
- 1992-11-02 JP JP50867593A patent/JP3504263B2/ja not_active Expired - Fee Related
- 1992-11-02 WO PCT/US1992/009430 patent/WO1993009229A1/en active IP Right Grant
- 1992-11-02 EP EP92924237A patent/EP0612348B1/de not_active Expired - Lifetime
- 1992-11-02 AU AU30622/92A patent/AU674500B2/en not_active Expired
- 1992-11-02 DE DE69233022T patent/DE69233022T2/de not_active Expired - Lifetime
- 1992-11-02 KR KR1019940701433A patent/KR100259827B1/ko not_active IP Right Cessation
- 1992-11-03 MX MX9206315A patent/MX9206315A/es unknown
- 1992-11-27 US US07/989,847 patent/US5866364A/en not_active Expired - Lifetime
-
1995
- 1995-06-06 US US08/469,411 patent/US6190880B1/en not_active Expired - Fee Related
-
2001
- 2001-02-09 US US09/780,601 patent/US6593109B1/en not_active Expired - Fee Related
-
2002
- 2002-07-22 JP JP2002212805A patent/JP2003125789A/ja active Pending
-
2003
- 2003-02-28 US US10/375,150 patent/US7678885B2/en not_active Expired - Fee Related
-
2007
- 2007-10-31 US US11/930,115 patent/US20090105137A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US7678885B2 (en) | 2010-03-16 |
US20030235888A1 (en) | 2003-12-25 |
AU674500B2 (en) | 1997-01-02 |
US5866364A (en) | 1999-02-02 |
US6190880B1 (en) | 2001-02-20 |
JPH07500968A (ja) | 1995-02-02 |
KR940703914A (ko) | 1994-12-12 |
EP0612348B1 (de) | 2003-04-23 |
AU3062292A (en) | 1993-06-07 |
DE69233022T2 (de) | 2004-02-12 |
ATE238417T1 (de) | 2003-05-15 |
JP3504263B2 (ja) | 2004-03-08 |
KR100259827B1 (ko) | 2000-06-15 |
US20090105137A1 (en) | 2009-04-23 |
MX9206315A (es) | 1993-05-01 |
WO1993009229A1 (en) | 1993-05-13 |
JP2003125789A (ja) | 2003-05-07 |
US6593109B1 (en) | 2003-07-15 |
EP0612348A1 (de) | 1994-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69233022D1 (de) | Rekombinante knochenmorphogenetische protein heterodimere, zusammensetzungen und verfahren zur verwendung | |
ES2113857T3 (es) | Composiciones osteoinductoras. | |
ATE265529T1 (de) | Bmp-10 zusammensetzungen | |
DK0536186T3 (da) | Knogle- og brusk-dannelsesfremkaldende proteiner | |
ATE212554T1 (de) | Gewebeabdeckung und wachstumsfaktor enthaltende verbindungen zur förderung beschleunigter wundheilung | |
DK0831884T3 (da) | Anvendelse af knoglemorfogenetiske proteiner til heling og reparation af bindevævsbinding | |
NL300116I1 (nl) | Nieuwe osteoinductieve samenstellingen. | |
DE69528058D1 (de) | Bmp-9 zusammensetzungen | |
ATE153696T1 (de) | Verfahren und desoxyribonukleinsäure zur herstellung von gewebefaktor-protein | |
ATE253631T1 (de) | Eine thrombin-blutfraktion zur verwendung in einem medizinischen verfahren | |
DK1378572T3 (da) | BMP-11-sammensætninger | |
ATE253589T1 (de) | Bmp-5-derivate | |
DE69128646D1 (de) | Verfahren und zusammensetzung zur behandlung von hyperproliferativen hauterkrankungen unter verwendung von 6-aminopurin-cytokininen | |
DE69434914D1 (de) | Verfahren und zusammensetzungen zur herstellung von rekombinantem osteogenischem protein | |
ATE161724T1 (de) | Verfahren und zusammensetzung zur behandlung von hyperproliferativen hauterkrankungen unter verwendung von 6-aminopurin-cytokininen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
R071 | Expiry of right |
Ref document number: 612348 Country of ref document: EP |